The Covid-19 pandemic has managed to push Big Pharma to pool their
resources to address the gaps in the infectious disease R&D and access
to medicine, a new study by the Amsterdam-based Access to Medicine
Index said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pharma-cos-making-their-products-more-accessible-/articleshow/80487431.cms
No comments:
Post a Comment